Squarepoint Ops LLC Syros Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$5.01 - $7.48 $379,407 - $566,460	-75,730 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.19 - $14.95 $332,702 - $691,781	46,273 Added 157.09%	75,730 $566,000
Q4 2020 Feb 16, 2021	BUY	$6.66 - $14.66 $115,564 - $254,380	17,352 Added 143.35%	29,457 $320,000
Q3 2020 Nov 16, 2020	BUY	$8.69 - $14.47 $105,192 - $175,159	12,105 New	12,105 $107,000
Q2 2020 Aug 14, 2020	SELL	$5.21 - $11.03 $59,977 - $126,977	-11,512 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$4.46 - $9.2 $149,352 - $308,080	-33,487 Reduced 74.42%	11,512 $68,000
Q4 2019 Feb 14, 2020	BUY	$4.52 - $10.1 $203,395 - $454,489	44,999 New	44,999 $311,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $4.25M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.